FDA comments on phase I clinical trials without vector biodistribution data

Citation
S. Epstein et al., FDA comments on phase I clinical trials without vector biodistribution data, NAT GENET, 22(4), 1999, pp. 326-326
Citations number
3
Categorie Soggetti
Molecular Biology & Genetics
Journal title
NATURE GENETICS
ISSN journal
10614036 → ACNP
Volume
22
Issue
4
Year of publication
1999
Pages
326 - 326
Database
ISI
SICI code
1061-4036(199908)22:4<326:FCOPIC>2.0.ZU;2-5